Role of TLR9 in Atherosclerosis? Therapeutic ODN in heart disease? - Chen, Yung-Chih
24,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
payback
12 °P sammeln
  • Broschiertes Buch

Atherosclerosis is the underlying pathology of diseases, such as coronary artery disease, resulting in major overall mortality and morbidity. It is a chronic inflammatory disease of the arterial wall, in which the innate immune system has a pivotal contribution. Toll-like receptor-9 (TLR9) is a major intracellular innate immune receptor that has attracted major interest and is currently clinically tested as a therapeutic target of inflammatory diseases. Using apolipoprotein E-deficient mice fed with high-fat diet during periods of 8 to 20 weeks as a model of atherosclerosis, we used a genetic…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
Atherosclerosis is the underlying pathology of diseases, such as coronary artery disease, resulting in major overall mortality and morbidity. It is a chronic inflammatory disease of the arterial wall, in which the innate immune system has a pivotal contribution. Toll-like receptor-9 (TLR9) is a major intracellular innate immune receptor that has attracted major interest and is currently clinically tested as a therapeutic target of inflammatory diseases. Using apolipoprotein E-deficient mice fed with high-fat diet during periods of 8 to 20 weeks as a model of atherosclerosis, we used a genetic (TLR9 deletion) and a pharmacological approach (TLR9 agonist) to demonstrate a protective role of TLR9 in atherosclerosis. We describe the modulation of cell numbers and inflammatory phenotype of CD4+ T cells as a potential mechanism. Moreover, we have identified a novel and attractive therapeutic approach to attenuate progression of atherosclerotic disease based on the use of TLR9-activating CpG oligodeoxynucleotides.
Autorenporträt
Yung-Chih Chen, diplômé en médecine vétérinaire, titulaire d'un master en biotechnologie et commerce à RMIT, docteur en médecine à l'université Monash. Chercheur en début de carrière à la Heart Foundation. Chargé de recherche au BakerIDI Heart and Diabetes Institute, Melbourne. Mes recherches portent sur les plaques athéroscléreuses instables et les modèles animaux de l'instabilité des plaques.